GlaxoSmithKline (GSK) Given a GBX 1,900 Price Target by Goldman Sachs Group Analysts – Fairfield Current
GlaxoSmithKline (LON:GSK) received a GBX 1,900 ($24.83) price objective from investment analysts at Goldman Sachs Group in a research note issued to investors on Wednesday. Jefferies Financial Group restated a “buy” rating and issued a GBX 1,580 ($20.65) price target on shares of GlaxoSmithKline in a report on Friday, October 12th. Two research analysts have rated the stock with a sell rating, eleven have issued a hold rating and seven have issued a buy rating to the company. Shares of GlaxoSmithKline stock traded up GBX 25.40 ($0.33) during trading on Wednesday, reaching GBX 1,548 ($20.23).